Q3
Predicted--
Actual$6.21
Today
Market Cap
917B
High Today
$1027.86
Low Today
$1002.89
Volume
1.93M
Open Price
$1010.82
52 Week High
$1132.87
52 Week Low
$623.78
Average Volume
68.2M
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Employees
47,000
Headquarters
INDIANAPOLIS, IN